BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34025829)

  • 1. Survival differences of patients with ureteral versus pelvicalyceal tumours: a systematic review and meta-analysis.
    Kaczmarek K; Lemiński A; Gołąb A; Słojewski M
    Arch Med Sci; 2021; 17(3):603-612. PubMed ID: 34025829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant carcinoma in situ as a prognostic factor in the upper tract urothelial carcinoma after radical nephroureterectomy: A systematic review and meta-analysis.
    Gao X; Ma Y; Chen G; Chen J; Li H; Li H; Wei X; Wang K
    Urol Oncol; 2020 Jun; 38(6):574-581. PubMed ID: 32273049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Primary Tumor Location on Long-Term Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy: A Systematic Review and Meta-Analysis.
    Krajewski W; Nowak Ł; Małkiewicz B; Chorbińska J; Kiełb P; Poterek A; Sporniak B; Sut M; Moschini M; Lonati C; Carando R; Teoh JY; Mori K; Kaliszewski K; Szydełko T; On Behalf Of The European Association Of Urology-Young Academic Urologists Eau-Yau Urothelial Carcinoma Working Group
    J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
    Seisen T; Peyronnet B; Dominguez-Escrig JL; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Cowan NC; Kaasinen E; Palou J; van Rhijn BW; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
    Eur Urol; 2016 Dec; 70(6):1052-1068. PubMed ID: 27477528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract.
    Wirth GJ; Haitel A; Moschini M; Soria F; Klatte T; Hassler MR; Bensalah K; Briganti A; Karam JA; Lotan Y; Margulis V; Raman JD; Remzi M; Rioux-Leclercq N; Robinson BD; Rouprêt M; Wood CG; Shariat SF
    World J Urol; 2017 Jun; 35(6):943-949. PubMed ID: 27730305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of preoperative blood-based biomarkers in upper tract urothelial carcinoma treated with nephroureterectomy: A systematic review and meta-analysis.
    Mori K; Janisch F; Mostafaei H; Lysenko I; Kimura S; Egawa S; Shariat SF
    Urol Oncol; 2020 May; 38(5):315-333. PubMed ID: 32088103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prevalence and Prognostic Role of PD-L1 in Upper Tract Urothelial Carcinoma Patients Underwent Radical Nephroureterectomy: A Systematic Review and Meta-Analysis.
    Lu Y; Kang J; Luo Z; Song Y; Tian J; Li Z; Wang X; Liu L; Yang Y; Liu X
    Front Oncol; 2020; 10():1400. PubMed ID: 32974145
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of tumour size on prognosis of upper urinary tract urothelial carcinoma after radical nephroureterectomy: a multi-institutional analysis of 795 cases.
    Shibing Y; Liangren L; Qiang W; Hong L; Turun S; Junhao L; Lu Y; Zhengyong Y; Yonghao J; Guangqing F; Yunxiang L; Dehong C
    BJU Int; 2016 Dec; 118(6):902-910. PubMed ID: 26935344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy.
    Leow JJ; Chong YL; Chang SL; Valderrama BP; Powles T; Bellmunt J
    Eur Urol; 2021 May; 79(5):635-654. PubMed ID: 32798146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profile of urothelial carcinoma of the upper urinary tract: are pelvicalyceal and ureteral tumors different?
    Krabbe LM; Bagrodia A; Westerman ME; Gayed BA; Haddad AQ; Sagalowsky AI; Shariat SF; Kapur P; Lotan Y; Margulis V
    World J Urol; 2016 Jan; 34(1):105-12. PubMed ID: 25991599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ki-67 as a Prognostic Marker in Upper Urinary Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
    Ahn C; Jeong CW; Kwak C; Kim HH; Kim HS; Ku JH
    Clin Genitourin Cancer; 2018 Aug; 16(4):e831-e841. PubMed ID: 29551582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
    Luo Y; Feng B; Wei D; Han Y; Li M; Zhao J; Lin Y; Hou Z; Jiang Y
    Sci Rep; 2020 Oct; 10(1):17674. PubMed ID: 33077839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.
    Shao Y; Li W; Wang D; Wu B
    World J Surg Oncol; 2020 Oct; 18(1):273. PubMed ID: 33097052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma.
    Kim HS; Ku JH; Jeong CW; Kwak C; Kim HH
    World J Urol; 2016 Jun; 34(6):859-69. PubMed ID: 26497823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Variant Histology in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Systematic Review and Meta-Analysis.
    Mori K; Janisch F; Parizi MK; Mostafaei H; Lysenko I; Kimura S; Enikeev DV; Egawa S; Shariat SF
    J Urol; 2020 Jun; 203(6):1075-1084. PubMed ID: 31479406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncological outcomes of laparoscopic versus open nephroureterectomy for the treatment of upper tract urothelial carcinoma: an updated meta-analysis.
    Piszczek R; Nowak Ł; Krajewski W; Chorbińska J; Poletajew S; Moschini M; Kaliszewski K; Zdrojowy R
    World J Surg Oncol; 2021 Apr; 19(1):129. PubMed ID: 33882936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the impact of different distal ureter management techniques during radical nephroureterectomy for primary upper urinary tract urothelial carcinoma on oncological outcomes: A systematic review and meta-analysis.
    Lai S; Guo R; Seery S; Wu P; Liu J; Zhang Y; Zhu S; Li X; Liu M; Wang J
    Int J Surg; 2020 Mar; 75():165-173. PubMed ID: 31978650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review and meta-analysis of oncological and renal function outcomes obtained after segmental ureterectomy versus radical nephroureterectomy for upper tract urothelial carcinoma.
    Fang D; Seisen T; Yang K; Liu P; Fan X; Singla N; Xiong G; Zhang L; Li X; Zhou L
    Eur J Surg Oncol; 2016 Nov; 42(11):1625-1635. PubMed ID: 27612412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients.
    Vartolomei MD; Kimura S; Ferro M; Vartolomei L; Foerster B; Abufaraj M; Shariat SF
    World J Urol; 2018 Jul; 36(7):1019-1029. PubMed ID: 29468284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.